Preclinical efficacy studies in investigator brochures: Do they enable risk–benefit assessment?

Title
Preclinical efficacy studies in investigator brochures: Do they enable risk–benefit assessment?
Authors
Keywords
Phase I clinical investigation, Clinical trials, Drug regulation, Medical ethics, Peer review, Phase II clinical investigation, Safety studies, Animal models
Journal
PLOS BIOLOGY
Volume 16, Issue 4, Pages e2004879
Publisher
Public Library of Science (PLoS)
Online
2018-04-06
DOI
10.1371/journal.pbio.2004879

Ask authors/readers for more resources

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search